BioMarin July calls active BioMarin July 65, 70 and 75 calls are active on total call volume of 8000 contracts (300 puts). July call option implied volatility is at 55, October is at 42; compared to its 26-week average of 42 according to Track Data. Active call volume suggests traders taking positions for price movement.
BioMarin upgraded to Buy from Neutral at Goldman Goldman upgraded BioMarin to Buy based on increased confidence in BMN-111 for achondroplasia with expected proof-of-concept data in Q2 2015. The firm now sees a greater than 50% probability of success and peak sales of $900M. Price target raised to $104 from $78.